Need for More Randomized Controlled Trials With Rigorous Methodology to Confirm That Ivermectin Is Not a Viable Option for the Treatment of Coronavirus Disease 2019.

Banno, Masahiro; Tsujimoto, Yasushi; Ishikane, Masahiro

Banno, Masahiro; Tsujimoto, Yasushi; Ishikane, Masahiro.

Banno M; Department of Psychiatry, Seichiryo Hospital, Showa-ku, Nagoya, Japan.
Tsujimoto Y; Department of Psychiatry, Nagoya University Graduate School of Medicine, Showa-ku, Nagoya, Japan.
Ishikane M; Systematic Review Workshop Peer Support Group, Osaka, Japan.

Clin Infect Dis ; 74(6): 1121-1122, 2022 03 23.

Article in English | MEDLINE | ID: covidwho-1344910

Subject(s)

COVID-19 Drug Treatment; Ivermectin; Humans; Ivermectin/therapeutic use; Randomized Controlled Trials as Topic; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Ivermectin / COVID-19 Drug Treatment Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: Cid

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google